TAG:
managed care plans
Connecticut Hospital Labs Win HMO Test Contracts
By Robert Michel | From the Volume VIII No. 9 – July 2, 2001 Issue
CEO SUMMARY: Connecticut Hospital Laboratory Network, LLC was formed in 1996 with the specific goal of winning managed care lab testing contracts. During the past five years it has steadily increased the number of patients covered by such contracts. Along the way, it has learned important…
Bio-Reference Labs, Sunquest, Beckman Coulter, Vysis
By Robert Michel | From the Volume VIII No. 9 – July 2, 2001 Issue
BIO-REFERENCE LABS REPORTS STRONG GROWTH IN REVENUE & EARNINGS LIKE MOST PUBLIC LAB COMPANIES, the financial news continues to be good at Bio-Reference Laboratories, Inc., based in Elmwood Park, NJ. For second quarter ending April 30, 2001, the lab reported revenues of …
DIANON Systems, UroCor, Cytyc, Digene, McKesson HBOC, Abaton.com, Abbott
By Robert Michel | From the Volume VIII No. 4 – March 19, 2001 Issue
FEDERAL ATTORNEY SERVES SUBPOENA ON DIANON SYSTEMS NEWS BROKE LAST WEEK that DIANON Systems, Inc. had received a subpoena from the U.S. Attorney’s Office in Connecticut for documents relating to laboratory billing. Apparently “LabScam” is still alive …
Merger Creates “New” Pathology Competitor
By Robert Michel | From the Volume VII No. 9 – June 19, 2000 Issue
CEO SUMMARY: Pathology business consolidation and regionalization continues. Pathology Consultants of America, Inc. (PCA) and PathSOURCE, Inc. announced their intention to merge last month. The combined company will be called Inform DX, Inc. and will compete nationally for anatomic pathol…
Independent California Lab Decides to Exit Business
By Robert Michel | From the Volume VII No. 5 – March 27, 2000 Issue
CEO SUMMARY: Market forces in California continue to put independent laboratories under sustained financial stress. One laboratory owner decided it was an auspicious time to sell his lab. That sale, of POISONLAB to Laboratory Corporation of America, was announced earlier this month. There…
Single-Specialty Path PPMs Posting Strong Growth, Profits
By Robert Michel | From the Volume VII No. 3 – February 14, 2000 Issue
CEO SUMMARY: Although the financial travails of the physician practice management (PPM) industry are widely known, there is little recognition that a number of single-specialty PPMs are doing well. This is true of pathology, where at least six pathology-based PPMs still remain in business…
“State of Lab Industry” Holds Surprises for All
By Robert Michel | From the Volume VII No. 1 – January 3, 2000 Issue
CEO SUMMARY: Say goodbye to several of the trends which shaped the lab industry during the 1990s, such as consolidation and government compliance programs. Although these trends won’t completely disappear, they will be superseded by a number of new transformational influences. During th…
1999’s Top Ten Stories Reflect Speed of Change
By Robert Michel | From the Volume VI No. 17 – December 13, 1999 Issue
CEO SUMMARY: This year’s round-up of the lab industry’s Top Ten most important stories lacks any compelling single theme. THE DARK REPORT’s conclusion? 1999 was a transition year. No new outside forces rattled the lab industry, allowing lab executives and pathologists to concentrate…
Lab Network in Florida Becoming Tough Player
By Robert Michel | From the Volume VI No. 17 – December 13, 1999 Issue
CEO SUMMARY: Throughout the 1990s, a growing number of hospital laboratory administrators learned the value of a professionally-managed lab outreach program. In a few markets, these savvy lab leaders moved to the next level: using regional laboratory networks to solidify their local marke…
California’s Physicians Face Financial Meltdown
By Robert Michel | From the Volume VI No. 14 – October 11, 1999 Issue
CEO SUMMARY: It’s a what-if scenario that may come true. Healthcare providers in the Golden State are going broke at an astounding rate. Physicians seem to be the hardest hit, but signs indicate that hospitals are also heading toward serious financial difficulties. In a nutshell, a deca…
CURRENT ISSUE

Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized